19-49461796-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_153329.4(ALDH16A1):c.755C>T(p.Pro252Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000267 in 1,610,506 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_153329.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALDH16A1 | NM_153329.4 | c.755C>T | p.Pro252Leu | missense_variant | 6/17 | ENST00000293350.9 | NP_699160.2 | |
ALDH16A1 | NM_001145396.2 | c.755C>T | p.Pro252Leu | missense_variant | 6/16 | NP_001138868.1 | ||
ALDH16A1 | XM_011526441.1 | c.668C>T | p.Pro223Leu | missense_variant | 6/17 | XP_011524743.1 | ||
ALDH16A1 | XM_047438163.1 | c.668C>T | p.Pro223Leu | missense_variant | 7/18 | XP_047294119.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ALDH16A1 | ENST00000293350.9 | c.755C>T | p.Pro252Leu | missense_variant | 6/17 | 1 | NM_153329.4 | ENSP00000293350.3 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152114Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000333 AC: 8AN: 240374Hom.: 0 AF XY: 0.0000229 AC XY: 3AN XY: 131086
GnomAD4 exome AF: 0.0000233 AC: 34AN: 1458392Hom.: 0 Cov.: 59 AF XY: 0.0000152 AC XY: 11AN XY: 725394
GnomAD4 genome AF: 0.0000592 AC: 9AN: 152114Hom.: 0 Cov.: 33 AF XY: 0.0000404 AC XY: 3AN XY: 74290
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 22, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at